“Mixed Duration” Or 90-Day Supply Of Chronic HBV Treatments Tied To Increased Patient Adherence, Research Indicates

Healio (3/16, Stulpin) reports, “Being prescribed a 90-day or a ‘mixed duration’ supply of entecavir or tenofovir disoproxil fumarate was associated with higher fill rates among commercially insured patients with chronic hepatitis B, researchers found.” R...